Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Non Operating Income: 2014-2025

Historic Non Operating Income for Mimedx Group (MDXG) over the last 8 years, with Sep 2025 value amounting to -$126,000.

  • Mimedx Group's Non Operating Income fell 500.00% to -$126,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$580,000, marking a year-over-year decrease of 70.09%. This contributed to the annual value of -$565,000 for FY2024, which is 2073.08% down from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's Non Operating Income is -$126,000, which was down 24.75% from -$101,000 recorded in Q2 2025.
  • Mimedx Group's Non Operating Income's 5-year high stood at $16,000 during Q4 2023, with a 5-year trough of -$237,000 in Q2 2024.
  • In the last 3 years, Mimedx Group's Non Operating Income had a median value of -$99,000 in 2024 and averaged -$87,455.
  • Its Non Operating Income has fluctuated over the past 5 years, first soared by 633.33% in 2023, then crashed by 5,050.00% in 2024.
  • Mimedx Group's Non Operating Income (Quarterly) stood at -$20,000 in 2021, then soared by 85.00% to -$3,000 in 2022, then soared by 633.33% to $16,000 in 2023, then slumped by 1,400.00% to -$208,000 in 2024, then slumped by 500.00% to -$126,000 in 2025.
  • Its Non Operating Income stands at -$126,000 for Q3 2025, versus -$101,000 for Q2 2025 and -$145,000 for Q1 2025.